Figures & data
Table 1. Gamma camera radionuclides.
Table 2. positron emission tomography radionuclides.
Figure 1. 99mTc-pertechnetate scan presentation of Graves’ disease (a), autonomously functioning thyroid nodules (b) and destructive thyroiditis (c).
![Figure 1. 99mTc-pertechnetate scan presentation of Graves’ disease (a), autonomously functioning thyroid nodules (b) and destructive thyroiditis (c).](/cms/asset/6ff14871-3096-4269-9903-c0a153251ecf/iere_a_2365776_f0001_oc.jpg)
Figure 2. 99mTc-pertechnetate (a) and 99mTc-MIBI (b) scans: cold and MIBI active nodules in both lobes (arrows). Histopathology: multifocal invasive follicular variant of papillary thyroid carcinoma.
![Figure 2. 99mTc-pertechnetate (a) and 99mTc-MIBI (b) scans: cold and MIBI active nodules in both lobes (arrows). Histopathology: multifocal invasive follicular variant of papillary thyroid carcinoma.](/cms/asset/c59d010b-2210-4027-b869-1056764c85f2/iere_a_2365776_f0002_b.gif)
Figure 4. Post-ablation131I SPECT/CT (B) in a young female affected by papillary thyroid carcinoma (pT2 Nx) showing a central neck lymph-node metastasis.
![Figure 4. Post-ablation131I SPECT/CT (B) in a young female affected by papillary thyroid carcinoma (pT2 Nx) showing a central neck lymph-node metastasis.](/cms/asset/b294a2bd-0655-489f-9269-acc9fb62d97b/iere_a_2365776_f0004_oc.jpg)
Figure 5. Post-therapy131I WBS (a, anterior; b, posterior views) and SPECT/CT (C) in a 50 years old female affected by papillary thyroid carcinoma (pT2 N1b) showing multiple visceral and skeletal radioiodine-avid metastases.
![Figure 5. Post-therapy131I WBS (a, anterior; b, posterior views) and SPECT/CT (C) in a 50 years old female affected by papillary thyroid carcinoma (pT2 N1b) showing multiple visceral and skeletal radioiodine-avid metastases.](/cms/asset/5e6e674c-e80f-4b82-bfee-e37106d0b183/iere_a_2365776_f0005_b.gif)
Figure 6. 18F-FDG PET maximum intensity projection image of a patient with poorly differentiated thyroid carcinoma showing increasing radiopharmaceutical uptake within the thyroid, corresponding to the primary tumor site and multiple lymph node, lung, liver, bone and renal metastases.
![Figure 6. 18F-FDG PET maximum intensity projection image of a patient with poorly differentiated thyroid carcinoma showing increasing radiopharmaceutical uptake within the thyroid, corresponding to the primary tumor site and multiple lymph node, lung, liver, bone and renal metastases.](/cms/asset/ec932f8a-7327-438b-9291-5b7e1b181e3b/iere_a_2365776_f0006_b.gif)
Figure 7. Parathyroid ultrasound: ovoidal hypoechoic nodule with vascular basket-pole, consistent with enlarged and hyperfunctioning parathyroid gland.
![Figure 7. Parathyroid ultrasound: ovoidal hypoechoic nodule with vascular basket-pole, consistent with enlarged and hyperfunctioning parathyroid gland.](/cms/asset/34b16f6d-2d55-4d9a-90ad-08164fc852a4/iere_a_2365776_f0007_oc.jpg)
Figure 8. 99mTc-MIBI dual phase scintigraphy: tracer uptake and late retention in a parathyroid adenoma (red arrow).
![Figure 8. 99mTc-MIBI dual phase scintigraphy: tracer uptake and late retention in a parathyroid adenoma (red arrow).](/cms/asset/1a3a7b18-5e3c-4320-8466-1137fd398468/iere_a_2365776_f0008_oc.jpg)